|
|
Volumn 15, Issue 4, 2001, Pages 287-289
|
|
What's new in the treatment of vitiligo
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIOXIDANT;
BASIC FIBROBLAST GROWTH FACTOR;
BERGAPTEN;
CALCIPOTRIOL;
CATALASE;
CORTICOSTEROID DERIVATIVE;
DERMATOLOGICAL AGENT;
ENDOTHELIN 1;
FLUOROURACIL;
FOLIC ACID;
HYDROGEN PEROXIDE;
KHELLIN;
LEUKOTRIENE C4;
LEVAMISOLE;
METHOXSALEN;
PHENYLALANINE;
POLYPODIUM LEUCOTOMOS EXTRACT;
PSORALEN;
RETINOIC ACID;
SCAVENGER;
TRANSFORMING GROWTH FACTOR ALPHA;
CATARACTOGENESIS;
CELL TRANSPLANTATION;
CONTROLLED STUDY;
CREAM;
DEPIGMENTATION;
DRUG ACTIVITY;
DRUG FORMULATION;
EDITORIAL;
ENDOCRINE DISEASE;
EPITHELIZATION;
ERBIUM YAG LASER;
HUMAN;
HUMAN CELL;
HUMAN EXPERIMENT;
HUMAN TISSUE;
IMMUNOMODULATION;
IMMUNOPATHOLOGY;
KERATINOCYTE;
MELANOCYTE;
MELANOGENESIS;
PATHOGENESIS;
PHOTOTHERAPY;
PHOTOTOXICITY;
PRIORITY JOURNAL;
PUVA;
SIDE EFFECT;
SKIN CANCER;
SKIN GRAFT;
T LYMPHOCYTE;
ULTRAVIOLET A RADIATION;
ULTRAVIOLET B RADIATION;
VITILIGO;
HUMANS;
METHOXSALEN;
OINTMENTS;
PUVA THERAPY;
SKIN PIGMENTATION;
VITILIGO;
|
|
EID: 0034749984
PISSN: 09269959
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1468-3083.2001.00290.x Document Type: Editorial |
|
Times cited : (12)
|
|
References (11)
|
